Related Experiment Video
Updated: Jan 1, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Structure-Activity Relationship in Pyrazolo[4,3-c]pyridines, First Inhibitors of PEX14-PEX5 Protein-Protein
Maciej Dawidowski1,2, Vishal C Kalel3, Valeria Napolitano4,5
1Center for Integrated Protein Science Munich at Chair of Biomolecular NMR, Department Chemie , Technische Universität München , Lichtenbergstrasse 4 , 85747 Garching , Germany.
Researchers developed new compounds to inhibit a key protein interaction in Trypanosoma parasites, offering a novel therapeutic strategy against these devastating infectious diseases.
Area of Science:
- Parasitology
- Drug Discovery
- Structural Biology
Background:
- Trypanosoma parasites cause severe diseases with limited treatment options.
- Existing therapies are often ineffective and have adverse side effects.
- Protein import into glycosomes is vital for parasite survival.
Purpose of the Study:
- To develop novel inhibitors targeting the PEX14-PEX5 protein-protein interaction (PPI).
- To identify compounds that disrupt essential parasite metabolic pathways.
- To provide new therapeutic leads against Trypanosoma infections.
Main Methods:
- Structure-guided computational screening and optimization.
- Utilized X-ray crystallography and NMR binding data.
- Employed molecular dynamics simulations for compound refinement.
Main Results:
- Developed the first compounds shown to inhibit the PEX14-PEX5 PPI.
- Demonstrated significant cellular activity against Trypanosoma parasites.
- Showed efficacy against Trypanosoma brucei gambiense and Trypanosoma cruzi.
Conclusions:
- Inhibiting the PEX14-PEX5 PPI is a viable strategy for Trypanosoma drug development.
- The novel compounds represent a promising new class of anti-parasitic agents.
- This approach targets essential parasite metabolism for therapeutic benefit.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Basicity of Heterocyclic Aromatic Amines
Protein-protein Interfaces
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling

